Precise Targeting
for Neurosurgery
RebrAIn aims to enhance patient outcomes in Parkinson’s Disease
and Essential Tremor treatments by combining
best-in-class supervised AI with clinically successful results.
RebrAIn is a spin-off of the University Hospital of Bordeaux and the Inria, based in the EU and the US, created by Professor Emmanuel Cuny, Neurosurgeon, and Professor Nejib Zemzemi, Researcher at Inria in Applied Mathematics, after 10 years of academic research and 2 theses.
RebrAIn’s service is a best-in-class, supervised AI-driven solution that streamlines complex, patient-specific neurosurgery by providing faster, simpler, and safer treatment through augmented neuromodulation planning.
Regulatory
CE marked,
FDA 510(k) cleared
Adoption
55 sites
worldwide
Indications
Parkinson’s disease (STN),
Essential tremor (VIM)
Volume
500+ targeting
operations performed
From T1 MRI upload to surgery planning,
RebrAIn services streamlines the pre-surgical planning process.
We have developed a targeting service that uses supervised AI algorithm & health data exchange platform to simplify and standardize neurosurgical procedures.
Our solution seamlessly integrate supervised AI-guided targeting into any workflow to streamline and standardize neurosurgical procedures.
* RebrAIn’ service leverages CE Marked and FDA 510(k) cleared Software as a Medical Device (SaMD), OptimMRI and OptimDBS.
With RebrAIn, we aim to enhance efficiency and peace of mind
for neurosurgeons and staff by providing millimetric MRI-guided
targeting of the STN or VIM based on a health data exchange platform.
Seamless integration
Surgery
under GA
Fast
workflow
Precise
surgery
Safe and efficient
Real Life impact
Testimony of a Parkinsonian patient treated on with the help of RebrAIn’ services
Testimony of an Essential Tremor patient treated on with the help of RebrAIn’ services
Real Life impact
Testimony of a Parkinsonian patient treated on with the help of RebrAIn’ services
Testimony of an Essential Tremor patient treated on with the help of RebrAIn’ services
Marked MRIs
worldwide
best-in-class
clinical data
Key anatomical
landmarks
Our latest public updates
ActuIA Features RebrAIn’s Innovations in Supervised AI-Driven Deep Brain Stimulation
We are excited to share that RebrAIn has been featured by ActuIA for our innovative work in neurosurgical targeting for Deep Brain Stimulation (DBS). The article highlights our supervised AI-driven solutions that significantly improve patient outcomes for those with...